Madison Avenue Partners, LP - 31 Dec 2025 SCHEDULE 13G/A Report for Indivior Pharmaceuticals, Inc. Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV)

Filing Manager
Madison Avenue Partners, LP
Reporting Manager
Madison Avenue International LP
Security
Indivior Pharmaceuticals, Inc. Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares")
Symbol
INDV
Shares outstanding
125,610,040 shares
Disclosed Ownership
6,280,502 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:57:13 UTC
Date of event
31 Dec 2025
Previous filing
18 Mar 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Madison Avenue International LP 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
Madison Avenue Partners, LP 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner of Madison Avenue Partners, LP
EMAI Management, LLC 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Managing Member
Madison Avenue GP, LLC 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Manager
Caraway Jackson Investments LLC 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Member
Eli Samaha 5% 6,280,502 0 6,280,502 /s/ Eli Samaha ELI SAMAHA